Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.
about
Crystal structure of an RNA aptamer bound to thrombinDevelopment of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonistAptamers in analytics.In vitro selection using a dual RNA library that allows primerless selectionFunctional nucleic acid sensorsSELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamersAptamer-targeted cell-specific RNA interferenceStrategies for the discovery of therapeutic aptamers.Recent developments in protein and cell-targeted aptamer selection and applicationsAcyclic identification of aptamers for human alpha-thrombin using over-represented libraries and deep sequencing.Development of a dual-aptamer-based multiplex protein biosensor.Synthetic biology: applications come of ageArginine-rich motifs present multiple interfaces for specific binding by RNA.A simple method for eliminating fixed-region interference of aptamer binding during SELEX.TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome.Nucleic acid aptamers as tools and drugs: recent developments.An in vitro compartmentalization-based method for the selection of bond-forming enzymes from large librariesNatural and engineered nucleic acids as tools to explore biology.Aptamer Selection Technology and Recent Advances.Iterative in situ click chemistry creates antibody-like protein-capture agents.Micromagnetic selection of aptamers in microfluidic channels.Aptamers and aptamer targeted delivery.Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.Alternative affinity tools: more attractive than antibodies?Characterisation of aptamers for therapeutic studies.A combinatorial systematic evolution of ligands by exponential enrichment method for selection of aptamer against protein targets.Trends in aptamer selection methods and applications.Cell-specific aptamers as emerging therapeutics.Nucleic acid aptamers in cancer research, diagnosis and therapy.Construction, stability, and activity of multivalent circular anticoagulant aptamers.In vitro selection of molecular beacons.Recent Progress in Aptamer-Based Functional Probes for Bioanalysis and Biomedicine.Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro.Selective aptamer-based control of intraneuronal signalingNucleic acid aptamers for target validation and therapeutic applications.Recent advances in microfluidic sample preparation and separation techniques for molecular biomarker analysis: A critical review.Aptamers in HIV research diagnosis and therapy.Programmable ligand-controlled riboregulators of eukaryotic gene expression.
P2860
Q24652403-B26DE7BE-504E-4F17-A754-D752202A85C2Q24799009-C87510C0-680A-4AE3-A4F7-261D57149B09Q28075607-C75EFE75-C5A1-489D-BBAF-7A97C14B47ACQ29036552-0257D25B-38D8-4FA2-9599-5BF09E49569CQ30481633-EC845CD3-F5AF-472E-B7B4-8D2047394D17Q33206025-F69AAC04-A8D5-476C-AAA2-7B7ABFF60392Q33272405-D2C29B3A-0E63-4E1C-9F64-A7C5BEC74649Q33717239-DA963A95-0CF8-4766-9342-41AC33A9F8E2Q33831862-85D2F017-B2F4-42C3-BF7E-3CB25B1E51C6Q33908491-78089471-6073-41C7-91C8-692611BBAB7BQ33916682-18099D3A-9F13-402E-9AD4-6CC75D322624Q33936041-FA9B51DD-FF16-4F1B-9CAF-45AA2620F64FQ33958771-613249BB-A94A-4BA6-B726-B20E85FA44CFQ34366716-D23117A3-A57A-4F50-B7B4-AA4312CC7549Q35181181-2F86C5DE-CA47-452B-9626-116992C51F49Q35234113-25F3DF1D-DF69-4F35-8E18-F746E9CF6A47Q35549348-2E08404C-1C57-4A6A-BD74-9ED4DCCE0DD4Q35902956-EA03EBBE-7012-4A9D-9513-D2C4B0AB20B6Q35986039-DEB0AA57-686E-4073-BFCD-568614E90A94Q36256736-1D451CD2-AFC5-4442-B5B1-4541EBE31263Q37027473-A138140E-A034-4032-972E-74AD04E84893Q37087131-9A17B524-6CD3-46A3-81DE-40585D7557A1Q37490756-C1B00D45-8D23-4E66-9B54-DB76E214C385Q37586838-FDB05D37-1BEF-4B0B-BD39-3CF3A2B7A31CQ37869534-F90CBF5F-7EC6-4795-A7C8-ACB3C66EA848Q38089865-3772507A-B283-4836-9C03-6F4A7CA87C66Q38296956-4DE86CF5-C807-4156-8199-D40670D64FB8Q38298067-75D7C7B5-C49C-49D3-85BE-401673FFDEACQ38302347-B3D38AB2-972B-4422-B8E2-F9BE8F035A63Q38308357-7E01F202-7B0C-4B44-951E-185CF7FCF153Q38337499-688A53E9-8C74-4676-B0D9-A5818B22FD76Q38350235-676DA914-F238-40BB-BEA1-B6EDAE7D30B1Q38848925-F24ACCCC-4A3F-4ADE-B13D-78F7581BD897Q39009713-7352D3A1-A60D-46F1-BFE3-2D50610E2AACQ41930742-26DD8B55-AEF2-441D-A00B-59AF1F4A869DQ42212423-3CDE72F8-3E3F-4013-A8F7-35DD0323E7EBQ43076601-37DA3B21-2C27-45CB-AEEA-2DE8BED02A0FQ47718653-C7A65D36-FE4A-4850-B92F-000C1E165521Q50066811-1522217A-0710-4E97-BA14-71576F920CDBQ51538187-110D9FE6-E04A-451A-B2DE-6F1C79DB0FBB
P2860
Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@ast
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@en
type
label
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@ast
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@en
prefLabel
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@ast
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@en
P2093
P2860
P50
P356
P1476
Automated selection of aptamer ...... n vitro: from gene to aptamer.
@en
P2093
J Colin Cox
Jay Hesselberth
Travis S Bayer
P2860
P356
10.1093/NAR/GNF107
P407
P577
2002-10-01T00:00:00Z